B of A Securities analyst Julien Dumoulin-Smith downgrades Edison (NYSE:EIX) from Neutral to Underperform.
SVB Leerink Upgrades BioNTech to Outperform, Lowers Price Target to $223
SVB Leerink analyst Daina Graybosch upgrades BioNTech (NASDAQ:BNTX) from Market Perform to Outperform and lowers the price target from $253 to $223.